Back to Authors

Shah, Mirat

https://orcid.org/0000-0003-0052-9978

A5084272541 | I1320320070

Mayo Clinic

United States Food and Drug Administration

Citations 1

Designing Dose-Optimization Studies in Cancer Drug Development: Discussions with Regulators

Statistics in Biopharmaceutical Research | January 9, 2023 | Volume: 15 | Issue: 3 | Pages: 697-703

10.1080/19466315.2023.2166099